Biogen cuts the price tag on its Alzheimer's drug in half

by Tom MurphyThe Biogen Inc., headquarters is shown March 11, 2020, in Cambridge, Mass. Biogen is slashing the price of its Alzheimer's treatment months after the drug debuted to widespread critic

Updated on: April 25,2024

Biogen cuts the price tag on its Alzheimer's drug in half

by Tom MurphyThe Biogen Inc., headquarters is shown March 11, 2020, in Cambridge, Mass. Biogen is slashing the price of its Alzheimer's treatment months after the drug debuted to widespread critic

Updated on:April 25,2024

Clinical trial suggests new drug candidate for spinocerebellar ataxia may offer certain therapeutic benefits

byNiigata UniversityL-arginine inhibits the aggregation of polyglutamine proteins in neuronal cells. Credit: Niigata UniversityA team has conducted a trial on the efficacy and safety of L-argini

Updated on: December 18,2024

Clinical trial suggests new drug candidate for spinocerebellar ataxia may offer certain therapeutic benefits

byNiigata UniversityL-arginine inhibits the aggregation of polyglutamine proteins in neuronal cells. Credit: Niigata UniversityA team has conducted a trial on the efficacy and safety of L-argini

Updated on:December 18,2024

Successful Phase 2 clinical trial for neflamapimod in mild-to-moderate Lewy body dementia

by University of North Carolina at Chapel Hill School of MedicineCredit: CC0 Public DomainEIP Pharma announced on October 6 that a phase 2 study in patients with mild-to-moderate Lewy body dement

Updated on: April 01,2024

Successful Phase 2 clinical trial for neflamapimod in mild-to-moderate Lewy body dementia

by University of North Carolina at Chapel Hill School of MedicineCredit: CC0 Public DomainEIP Pharma announced on October 6 that a phase 2 study in patients with mild-to-moderate Lewy body dement

Updated on:April 01,2024

Inflammation-triggering cellular pathway identified as potential new drug target for Alzheimer's disease

Updated on: March 09,2025

Inflammation-triggering cellular pathway identified as potential new drug target for Alzheimer's disease

Updated on:March 09,2025

Link found between chronic inflammation and risk for Alzheimer's disease

by Boston University School of MedicineWhile it is widely shown that possessing the ApoE4 gene is the major genetic risk factor of Alzheimer's disease (AD), not all ApoE4 carriers develop AD.

Updated on: March 07,2024

Link found between chronic inflammation and risk for Alzheimer's disease

by Boston University School of MedicineWhile it is widely shown that possessing the ApoE4 gene is the major genetic risk factor of Alzheimer's disease (AD), not all ApoE4 carriers develop AD.

Updated on:March 07,2024

Genetic and non-genetic resilience against memory decline and Alzheimer's

by Alzheimer's Research UKResearchers across the world are keen to understand why some people experience memory decline or diseases like Alzheimer's, while others don't. At AAIC2016,

Updated on: March 07,2024

Genetic and non-genetic resilience against memory decline and Alzheimer's

by Alzheimer's Research UKResearchers across the world are keen to understand why some people experience memory decline or diseases like Alzheimer's, while others don't. At AAIC2016,

Updated on:March 07,2024

Targeted preventive measures for hip fracture are needed for persons with Alzheimer's disease

by University of Eastern FinlandThe hip fracture risk factors are generally similar among those with and without Alzheimer's disease, according to a recent study from the University of Easter

Updated on: March 07,2024

Targeted preventive measures for hip fracture are needed for persons with Alzheimer's disease

by University of Eastern FinlandThe hip fracture risk factors are generally similar among those with and without Alzheimer's disease, according to a recent study from the University of Easter

Updated on:March 07,2024

New data resource for dementia research

by Oxford UniversityAn Oxford University-led research programme has launched a new system to help dementia researchers make the most of existing study data. The Dementias Platform UK's new&nb

Updated on: February 26,2024

New data resource for dementia research

by Oxford UniversityAn Oxford University-led research programme has launched a new system to help dementia researchers make the most of existing study data. The Dementias Platform UK's new&nb

Updated on:February 26,2024

Investigating specific pathological features of cerebral cavernous malformation in children

by Katie Paradis,Children's Hospital BostonCredit: CC0 Public DomainChildren with cavernous malformations face unique treatment challenges due to factors such as the malformation's locat

Updated on: November 28,2024

Investigating specific pathological features of cerebral cavernous malformation in children

by Katie Paradis,Children's Hospital BostonCredit: CC0 Public DomainChildren with cavernous malformations face unique treatment challenges due to factors such as the malformation's locat

Updated on:November 28,2024

Fiber supplements could improve brain function in seniors, study says

by Ebony Williams, The Atlanta Journal-ConstitutionCredit: Wikimedia CommonsFiber is essential for the digestive system. It helps maintain a healthy weight and lowers the risk of diabetes, heart disea

Updated on: March 28,2024

Fiber supplements could improve brain function in seniors, study says

by Ebony Williams, The Atlanta Journal-ConstitutionCredit: Wikimedia CommonsFiber is essential for the digestive system. It helps maintain a healthy weight and lowers the risk of diabetes, heart disea

Updated on:March 28,2024

International study uncovers a molecule that could alleviate stroke-related brain injury

byThe Hospital for Sick ChildrenCredit: CC0 Public DomainA newly developed molecule, LK-2, could inform new therapies for stroke-related brain injury, find scientists at The Hospital for Sick Ch

Updated on: July 17,2024

International study uncovers a molecule that could alleviate stroke-related brain injury

byThe Hospital for Sick ChildrenCredit: CC0 Public DomainA newly developed molecule, LK-2, could inform new therapies for stroke-related brain injury, find scientists at The Hospital for Sick Ch

Updated on:July 17,2024

FDA approves first drug meant to ease Alzheimer's-linked agitation

by Cara MurezA medication to treat agitation in Alzheimer's patients now has approval from the U.S. Food and Drug Administration.The FDA gave supplemental approval to Otsuka Pharmaceutical Company

Updated on: March 30,2024

FDA approves first drug meant to ease Alzheimer's-linked agitation

by Cara MurezA medication to treat agitation in Alzheimer's patients now has approval from the U.S. Food and Drug Administration.The FDA gave supplemental approval to Otsuka Pharmaceutical Company

Updated on:March 30,2024